Brief: Yichang Hec Changjiang Pharma Got CSRC Approval For Full Circulation Of H Shares
June 3 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* SAYS GOT FORMAL APPROVAL LETTER ON JUNE 2 FROM CSRC FOR
FULL
CIRCULATION OF H SHARES
* PURSUANT TO APPROVAL, 226.2 MILLION DOMESTIC UNLISTED
SHARES
HELD BY GUANGDONG HEC TECHN COULD BE CONVERTED INTO H SHARES
Source text for Eikon: ID:nHKS9nzRYT
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million